American International Group Inc. Has $5.03 Million Position in Cooper Companies Inc (COO)

American International Group Inc. boosted its holdings in Cooper Companies Inc (NYSE:COO) by 6.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,156 shares of the medical device company’s stock after purchasing an additional 1,023 shares during the period. American International Group Inc.’s holdings in Cooper Companies were worth $5,032,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Bradley Foster & Sargent Inc. CT grew its position in Cooper Companies by 10.1% in the third quarter. Bradley Foster & Sargent Inc. CT now owns 2,184 shares of the medical device company’s stock valued at $605,000 after purchasing an additional 200 shares in the last quarter. Penserra Capital Management LLC grew its position in shares of Cooper Companies by 16.5% in the 3rd quarter. Penserra Capital Management LLC now owns 1,564 shares of the medical device company’s stock valued at $433,000 after acquiring an additional 221 shares during the period. Bronfman E.L. Rothschild L.P. grew its position in shares of Cooper Companies by 6.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 3,622 shares of the medical device company’s stock valued at $853,000 after acquiring an additional 232 shares during the period. Nomura Asset Management Co. Ltd. grew its position in shares of Cooper Companies by 1.3% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 19,770 shares of the medical device company’s stock valued at $4,655,000 after acquiring an additional 262 shares during the period. Finally, First Mercantile Trust Co. grew its position in shares of Cooper Companies by 4.9% in the 3rd quarter. First Mercantile Trust Co. now owns 5,627 shares of the medical device company’s stock valued at $1,560,000 after acquiring an additional 263 shares during the period.

COO has been the subject of a number of analyst reports. BMO Capital Markets lifted their price objective on shares of Cooper Companies from $280.00 to $285.00 and gave the company an “outperform” rating in a research report on Friday, August 31st. Oppenheimer set a $270.00 price objective on shares of Cooper Companies and gave the company a “hold” rating in a research report on Friday, August 31st. Raymond James lifted their price objective on shares of Cooper Companies from $270.00 to $300.00 and gave the company an “outperform” rating in a research report on Friday, September 21st. Zacks Investment Research downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Thursday, August 16th. Finally, ValuEngine raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Thursday, September 27th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Cooper Companies currently has an average rating of “Buy” and an average target price of $276.22.

Shares of COO opened at $277.03 on Friday. The stock has a market capitalization of $13.51 billion, a PE ratio of 28.56, a PEG ratio of 2.10 and a beta of 0.77. The company has a quick ratio of 1.54, a current ratio of 2.58 and a debt-to-equity ratio of 0.70. Cooper Companies Inc has a one year low of $216.47 and a one year high of $283.18.

Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, December 6th. The medical device company reported $2.87 EPS for the quarter, missing the consensus estimate of $2.96 by ($0.09). The company had revenue of $651.50 million for the quarter, compared to the consensus estimate of $645.25 million. Cooper Companies had a return on equity of 17.53% and a net margin of 5.23%. The business’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.65 EPS. On average, research analysts forecast that Cooper Companies Inc will post 11.61 earnings per share for the current fiscal year.

In related news, Director Allan E. Rubenstein sold 1,500 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.37, for a total transaction of $398,055.00. Following the completion of the sale, the director now owns 3,068 shares of the company’s stock, valued at approximately $814,155.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Daniel G. Mcbride sold 10,310 shares of Cooper Companies stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $264.44, for a total transaction of $2,726,376.40. Following the sale, the chief operating officer now directly owns 38,705 shares of the company’s stock, valued at approximately $10,235,150.20. The disclosure for this sale can be found here. Insiders have sold a total of 20,691 shares of company stock valued at $5,527,869 in the last ninety days. 1.60% of the stock is currently owned by insiders.

WARNING: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/12/07/american-international-group-inc-has-5-03-million-position-in-cooper-companies-inc-coo.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Featured Article: Is it better to buy a fund with a higher or lower NAV?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply